Merck is expanding its membrane and filtration manufacturing capabilities in Ireland. The company will invest approximately €440 million.

Company to invest in two major Life Science projects over five years
Significantly increases membrane manufacturing capacities and enables construction of new filtration manufacturing facility
Supports Merck’s strategy to invest in products and technologies across its portfolio that are key to manufacturing novel therapies, vaccines and diagnostics
Investment creates more than 370 jobs by the end of 2027